Studies show that older patients are particularly susceptible to many neurologic diseases including Alzheimer’s, epilepsy, Parkinson’s, and stroke. In addition to the terrible human toll of neurologic disorders, the diseases annually cost the U.S. economy hundreds of billions of dollars in care, lost work-days, and reduced productivity -- Alzheimer’s disease alone costs more than $148 billion a year, according to The Alzheimer Association.

Backgrounder: Selected Medicines In Development For Neurologic Disorders